International Patent: ANTIGEN RECOGNIZING CONSTRUCT CAPABLE OF BINDING TO A PREFERENTIALLY EXPRESSED ANTIGEN IN MELANOMA (PRAME) PEPTIDE AND A T CELL RECEPTOR (TCR) HAVING ANTIGENIC SPECIFICITY FOR PRAME FOR USE IN A METHOD OF TREATING A DISEASE IN A SUBJECT AS WELL AS CORRESPONDING T-CELLS, NUCLEIC ACID SEQUENCES, VECTORS, PHARMACEUTICAL COMPOSITIONS AND KITS

GENEVA, Aug. 14 -- T-KNIFE GMBH filed a patent application (EP2026/053051) for “ANTIGEN RECOGNIZING CONSTRUCT CAPABLE OF BINDING TO A PREFERENTIALLY EXPRESSED ANTIGEN IN MELANOMA (PRAME) PEPTIDE AND A T CELL RECEPTOR (TCR) HAVING ANTIGENIC SPECIFICITY FOR PRAME FOR USE IN A METHOD OF TREATING A DISEASE IN A SUBJECT AS WELL AS CORRESPONDING T-CELLS, NUCLEIC ACID SEQUENCES, VECTORS, PHARMACEUTICAL COMPOSITIONS AND KITS”. With publication no. WO/2026/167100, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 14/725

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organiz...